NLS PHARMACEUTICS LTD COM NEW
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for NLS PHARMACEUTICS LTD COM NEW Stock, CUSIP H57830103.
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for NLS PHARMACEUTICS LTD COM NEW Stock, CUSIP H57830103.